Laboratory Procedure for Pancreatic Neoplasm

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mayo Clinic in Rochester, Rochester, MN
Pancreatic Neoplasm+3 More
Laboratory Procedure - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing if nanopore sequencing can help detect bacteria that leads to surgical site infections in patients with pancreatic tumors. Laboratory Procedure is used to treat Pancreatic Neoplasm. This treatment involves immunotherapy and has previously been approved by the FDA for a different condition. No patients in this trial will receive a placebo. This treatment is free.

Eligible Conditions

  • Pancreatic Neoplasm
  • Benign Pancreatic Neoplasm

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Pancreatic Neoplasm

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: Up to 2 years

Up to 2 years
Change in Cost effectiveness in study arms for binary variables using chi-square testing
Change in Cost effectiveness in study arms for binary variables using fisher's exact testing
Change in Cost effectiveness in study arms for cost variables using t-test
Change in Improved antibiotic stewardship in study arms binary variables using chi-square testing
Change in Improved antibiotic stewardship in study arms binary variables using fisher's exact testing
Change in Improved antibiotic stewardship in study arms for cost variables using t-test
Change in surgical site infections
Timeliness of sample analysis

Trial Safety

Safety Progress

1 of 3

Other trials for Pancreatic Neoplasm

Trial Design

2 Treatment Groups

Arm I (biospecimen collection, routine testing)
1 of 2
Arm II (biospecimen, nanopore sequencing, routine testing)
1 of 2
Active Control
Experimental Treatment

140 Total Participants · 2 Treatment Groups

Primary Treatment: Laboratory Procedure · No Placebo Group · Phase < 1

Arm II (biospecimen, nanopore sequencing, routine testing)Experimental Group · 3 Interventions: Laboratory Procedure, Biospecimen Collection, Oxford Nanopore Sequencing · Intervention Types: Other, Procedure, Device
Arm I (biospecimen collection, routine testing)ActiveComparator Group · 2 Interventions: Laboratory Procedure, Biospecimen Collection · Intervention Types: Other, Procedure
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 1
~430

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 2 years
Closest Location: Mayo Clinic in Rochester · Rochester, MN
Photo of Rochester 1Photo of Rochester 2Photo of Rochester 3
2021First Recorded Clinical Trial
0 TrialsResearching Pancreatic Neoplasm
513 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,864 Previous Clinical Trials
3,696,343 Total Patients Enrolled
National Cancer Institute (NCI)NIH
12,937 Previous Clinical Trials
41,301,865 Total Patients Enrolled
Nicholas D ChiaPrincipal InvestigatorMayo Clinic in Rochester

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are pregnant.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.